XERIS BIOPHARMA HLDGS INC COM USD0.0001 earnings per share and revenue

0A8E earnings per share for the last quarter are -0.10 USD whereas the estimation was -0.10 USD which accounts for -3.11% surprise. Company revenue for the same period amounts to 46.51 M USD despite the estimated figure of 45.84 M USD. Estimated earnings per share for the next quarter are -0.09 USD, and revenue is expected to reach 51.45 M USD. Also watch annual changes over time to get a bigger picture of 0A8E earnings per share and revenue dynamics.